Clinical Trial Update: Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update evaluating Trastuzumab Rezetecan plus Pertuzumab in the neoadjuvant treatment of HER2-positive breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• Trastuzumab Rezetecan

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING